ArticleGenes2023

High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer.

Inga Reynisdottir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.